ArticleBMJ open2024

An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.

Rachel L Sagar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.